The Post-Finasteride Syndrome: An Overview

    September 2016 in “ Journal of Mind and Medical Sciences ”
    David L. Rowland, Ion G. Motofei, F Popa, Vlad Denis Constantin, Adriana Vasilache, Ioana Paunica, Cristian Balalau, Georgeta P. Păunică, Petrisor Banu, Stana Paunica
    Image of study
    TLDR Finasteride can cause side effects, some lasting after treatment ends, and may lead to severe depression or suicidal thoughts.
    The 2016 study "The postfinasteride syndrome; an overview" discussed the side effects of Finasteride, a 5-α reductase inhibitor used to treat male androgenic alopecia and benign prostatic hyperplasia. The study highlighted that while Finasteride is effective, its therapeutic results only last as long as the drug is administered, with symptoms typically returning after treatment cessation. Furthermore, several adverse effects were reported during the therapeutic phase, some of which persisted long or indefinitely after treatment cessation, a condition known as "post-finasteride syndrome." The study suggested that side effects during treatment and post-treatment should be addressed separately. It was also noted that hand preference and sexual orientation could be potential predictors for Finasteride side effects and post-finasteride syndrome. The study urged caution with Finasteride administration due to reports of severe depressive episodes, including suicidal thoughts, partly due to persistent sexual side effects.
    Discuss this study in the Community →

    Research cited in this study

    29 / 29 results

    Related Community Posts Join

    6 / 1000+ results

      community New and Interesting HairLoss Studies/Papers/Reviews

      in Treatment  42 upvotes 4 years ago
      Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 4 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Massive study on finasteride side effects released

      in Finasteride/Dutasteride  83 upvotes 2 years ago
      The release of a study on 5a-reductase inhibitors (finasteride and dutasteride) which showed an increased risk of depression, dementia, decreased libido, and reduced semen load as potential side effects; discussion around other forms of hair loss treatments such as topical minoxidil, RU58841, or opting to accept baldness; and advice to consider professional help for deeper issues related to hair loss.

      community Hair Loss Drugs Ranked in Order of Efficacy

      in Research/Science  67 upvotes 1 year ago
      Dutasteride is likely the most effective treatment for male pattern baldness, followed by finasteride and minoxidil in various forms and dosages. Users discuss personal experiences, dosages, and potential side effects, with some considering combining treatments for better results.

    Related Research

    15 / 15 results